The two most prominent GLP-1 medications for weight loss are: Semaglutide (brand names Wegovy and Ozempic): Originally developed for type 2 diabetes, semaglutide has shown remarkable weight loss results in clinical trials, with participants losing an average of 14.9% of their body weight
Furthermore, Sod1 mutant mice also exhibit wide-ranging deregulation of their lipid metabolism, including peripheral hypolipidemia [41, 52, 83] and upregulated levels of ceramides, glucosylceramides and glycosphingolipids [42, 64, 155]
NO REAL SUBSTANTIVE TRIALS
Ann Thorac Surg 109(2):358-366, 2020
(2002): Identified the redox potential of the GSH/GSSG couple as a key determinant of cellular signaling, immune modulation, and apoptosis
Regulatory measures, from the FDAs Compounding Risk Alert to DOJ prosecutions of pharmacies that dispensed unapproved peptides, cement the narrative that access and quality are legitimate issues